Target intelligence / Profile preview

NHL-repeat-containing protein 4 (NHLRC4)

Target: NHLRC4
Molecular classification: Other (belongs to the NHL-repeat protein family, not an enzyme, receptor, ion channel, transporter, or transcription factor; it is in the broader class of repeat domain-containing proteins)

Overview

NHL-repeat-containing protein 4 (NHLRC4) is a human protein encoded by the NHLRC4 gene (NCBI Gene: 283948) and is part of the NHL-repeat protein family[5][1][3]. NHL repeats are protein structural motifs named for Ncl-1, HT2A, and Lin-41 founding members, generally associated with protein-protein or protein-RNA binding[4][2]. NHLRC4 is broadly expressed, but its biological role in humans remains poorly characterized and distinct from more widely studied TRIM-NHL or LIN41-like family members, which are known to regulate mRNA translation or stability through their RNA-binding capacity in gene regulatory networks[2][6]. Unlike some other NHL-repeat proteins (e.g., TRIM71, LIN41), NHLRC4 does not appear to act as a canonical RNA regulator, transcription factor, or receptor, and there is no evidence supporting its role in human disease pathogenesis or as a therapeutic target. Currently, NHLRC4 should be classified as a repeat-domain containing protein with undefined and not fully elucidated biological function in molecular biology and genomics[5][1][3].

Other names: NHL repeat containing 4NHLRC4NHLC4_HUMANNHL-repeat-containing protein 4

Biological functions

The specific molecular function of human NHLRC4 is not well characterized.However, NHL-repeat proteins are generally associated with RNA- or protein-binding, regulation of mRNA expression, and post-transcriptional gene regulation in related family members.No canonical signaling or immune regulatory function is described for NHLRC4.

Disease associations

No direct disease role for NHLRC4 is defined in current curated databases.Mutational or expression associations may be identified in high-throughput datasets, but there is no established relationship with cancer, inflammation, neurodegeneration or infection per standard resources.

Beyond the preview

Go deeper on NHL-repeat-containing protein 4 (NHLRC4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NHL-repeat-containing protein 4 (NHLRC4).

Explore the full profile